Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Xeris Biopharma Holdings
XERS
$1.95B
| $11.4M | 0.02% |
1,434,433
+577,620
| +67% | +$3.69M |
2024 Q3
7 quarters
|
|
652
LifeMD
LFMD
$111M
| $11.3M | 0.02% |
2,747,655
+1,728,578
| +170% | +$7.63M |
2025 Q2
4 quarters
|
|
653
AvePoint
AVPT
$3.62B
| $11.3M | 0.02% |
1,011,315
+286,906
| +40% | +$2.95M |
2022 Q4
14 quarters
|
|
654
Celcuity
CELC
$3.38B
| $11.3M | 0.02% |
107,981
-11,067
| -9% | -$1.28M |
2026 Q1
1 quarter
|
|
655
Hubbell
HUBB
$22.3B
| $11.3M | 0.02% |
21,554
-52,062
| -71% | -$26.3M |
2015 Q4
42 quarters
|
|
656
Arvinas
ARVN
$514M
| $11.3M | 0.02% |
1,356,032
+215,317
| +19% | +$2.01M |
2023 Q3
11 quarters
|
|
657
TG Therapeutics
TGTX
$9.36B
| $11.3M | 0.02% |
204,915
+177,325
| +643% | +$7.26M |
2026 Q1
1 quarter
|
|
658
Fulton Financial
FULT
$4.48B
| $11.3M | 0.02% |
465,261
+44,802
| +11% | +$982K |
2013 Q2
52 quarters
|
|
659
EnerSys
ENS
$5.77B
| $11.2M | 0.02% |
48,020
-6,832
| -12% | -$1.48M |
2013 Q2
52 quarters
|
|
660
General Mills
GIS
$18.3B
| $11.2M | 0.02% |
321,912
-621,730
| -66% | -$21.5M |
2013 Q2
52 quarters
|
|
661
Acuity Brands
AYI
$9.5B
| $11.2M | 0.02% |
29,603
+1,410
| +5% | +$418K |
2017 Q4
34 quarters
|
|
662
Hudbay
HBM
$9.6B
| $11.1M | 0.02% |
472,054
+471,707
| +135,939% | +$11.9M |
2021 Q2
20 quarters
|
|
663
FuelCell Energy
FCEL
$897M
| $11.1M | 0.02% |
309,368
-34,451
| -10% | -$559K |
2024 Q4
6 quarters
|
|
664
Insperity
NSP
$1.85B
| $11M | 0.02% |
267,422
-65,718
| -20% | -$2.15M |
2015 Q1
45 quarters
|
|
665
Pembina Pipeline
PBA
$29.9B
| $11M | 0.02% |
238,329
-2,908
| -1% | -$135K |
2022 Q3
15 quarters
|
|
666
The RMR Group
RMR
$285M
| $11M | 0.02% |
535,817
+8,513
| +2% | +$161K |
2019 Q3
27 quarters
|
|
667
Cogent Biosciences
COGT
$5.38B
| $11M | 0.02% |
282,979
-2,682
| -0.9% | -$93.8K |
2024 Q2
8 quarters
|
|
668
Mama's Creations
MAMA
$598M
| $10.9M | 0.02% |
610,000
-359
| -0.1% | -$5.44K |
2025 Q4
2 quarters
|
|
669
Qualys
QLYS
$7.75B
| $10.9M | 0.02% |
79,056
-101,204
| -56% | -$10M |
2017 Q4
34 quarters
|
|
670
Tecnoglass Holdings
TGLS
$1.71B
| $10.8M | 0.02% |
+231,551
| New | +$10M |
2026 Q2
0 quarters
|
|
671
Vulcan Materials
VMC
$36.1B
| $10.8M | 0.02% |
36,654
-1,343
| -4% | -$385K |
2015 Q1
45 quarters
|
|
672
Franklin Covey
FC
$204M
| $10.8M | 0.02% |
440,154
+28
| +0% | +$638 |
2019 Q2
28 quarters
|
|
673
Zoetis
ZTS
$32.9B
| $10.7M | 0.02% |
149,060
-303,920
| -67% | -$28.6M |
2013 Q2
52 quarters
|
|
674
Cognex
CGNX
$9.45B
| $10.6M | 0.02% |
146,655
-1,099,298
| -88% | -$66.7M |
2014 Q3
47 quarters
|
|
675
Prothena Corp
PRTA
$435M
| $10.6M | 0.02% |
1,084,401
+24,552
| +2% | +$242K |
2024 Q2
8 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.